TickerFacts.

Sionna Therapeutics, Inc. (SION): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$66.30M
Year ended 2025-12-31
-$75.92M
Trailing 12 months to 2026-06-30
2024-12-31: -$52.79M2025-12-31: -$66.30M-$66.30M
2024-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$66.30Mn/m2026-03-02, From 2025-01-01
2024-12-31-$52.79Mn/a2026-03-02, From 2024-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Sionna Therapeutics, Inc. (SION)2025-12-31-$66.30Mn/m
Omeros Corp (OMER)2025-12-31-$116.09Mn/m
Prothena Corp Public Ltd Co (PRTA)2025-12-31-$163.58Mn/m
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31-$170.87Mn/m
Liquidia Corp (LQDA)2025-12-31-$35.69Mn/m
ADC Therapeutics SA (ADCT)2025-12-31-$141.17Mn/m
Rocket Pharmaceuticals, Inc. (RCKT)2025-12-31-$190.01Mn/m
Amylyx Pharmaceuticals, Inc. (AMLX)2025-12-31-$123.34Mn/m
ArriVent BioPharma, Inc. (AVBP)2025-12-31-$160.59Mn/m

Compare SION, OMER, PRTA, SPRY side by side · Screen every company in Pharmaceutical Preparations ↗